Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum

التفاصيل البيبلوغرافية
العنوان: Effect of maternal diabetes on phosphorylation of insulin-like growth factor binding protein-1 in cord serum
المؤلفون: Mikko Loukovaara, E Nurminen, Kari Teramo, Pekka Leinonen, Eeva-Marja Rutanen, Sture Andersson
المصدر: Diabetic Medicine. 22:434-439
بيانات النشر: Wiley, 2005.
سنة النشر: 2005
مصطلحات موضوعية: Adult, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Birth weight, Pregnancy in Diabetics, Pregnancy Proteins, Umbilical cord, Insulin-like growth factor-binding protein, Immunoenzyme Techniques, Endocrinology, Pregnancy, Internal medicine, Diabetes mellitus, Internal Medicine, medicine, Birth Weight, Humans, Protein Isoforms, Phosphorylation, Type 1 diabetes, Fetus, biology, business.industry, Fetal Blood, medicine.disease, Insulin-Like Growth Factor Binding Protein 1, Insulin-Like Growth Factor Binding Proteins, Gestational diabetes, Diabetes, Gestational, Diabetes Mellitus, Type 1, medicine.anatomical_structure, biology.protein, Female, business
الوصف: Aims The insulin-like growth factor (IGF) system is considered important in the regulation of fetal growth. Binding of IGFs to specific binding proteins (IGFBPs) modifies their actions. In fetal blood, IGFBP-1 is the primary IGF binding protein whose phosphorylation generates proteins with different affinities for IGF-I. We studied cord serum IGFBP-1 phosphoisoform profiles in normal pregnancies and in diabetic pregnancies, which are frequently complicated by macrosomia. Research design and methods Cord serum IGFBP-1 phosphoisoform concentrations were measured at birth by two immunoenzymometric assays in 67 pregnancies complicated by Type 1 diabetes, in 28 pregnancies complicated by insulin-treated gestational diabetes, and in 62 normal pregnancies. Results Cord serum highly phosphorylated IGFBP-1 (hpIGFBP-1) concentrations were lower in pregnancies complicated by Type 1 diabetes (204 +/- 36 microg/l, P = 0.032) and in pregnancies complicated by gestational diabetes (170 +/- 28 microg/l, P = 0.031) than in controls (316 +/- 34 microg/l). Cord serum lesser phosphorylated IGFBP-1 (lpIGFBP-1) concentrations were similar in diabetic and normal pregnancies (P = 0.692 between groups by analysis of variance). Relative birth weight correlated negatively with cord serum hpIGFBP-1 and lpIGFBP-1 in diabetic pregnancies, and with cord serum lpIGFBP-1 in normal pregnancies. Conclusions Maternal diabetes is associated with suppressed hpIGFBP-1 but unaltered lpIGFBP-1 concentrations in cord serum, suggesting that IGFBP-1 phosphoisoforms are differentially regulated in the fetus. Because hpIGFBP-1 has a higher affinity for IGF-I than does lpIGFBP-1, diabetes-related changes in fetal IGFBP-1 phosphorylation may increase IGF-I bioavailability and, consequently, stimulate fetal growth. This may partly explain the increased occurrence of macrosomia in diabetic pregnancies.
تدمد: 1464-5491
0742-3071
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05dee72280103bfbb5e439cfab9c44aeTest
https://doi.org/10.1111/j.1464-5491.2005.01430.xTest
حقوق: CLOSED
رقم الانضمام: edsair.doi.dedup.....05dee72280103bfbb5e439cfab9c44ae
قاعدة البيانات: OpenAIRE